Clinical Trial Update: Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial

View source ↗

Summary

A completed analysis within the COG-AAML0431 trial looked at DNA samples from younger patients with Down syndrome and acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Down Syndrome

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Status: COMPLETED